Jump to content
Powered by

Red biotechnology

The latest articles, press releases and dossiers on red biotechnology in Baden-Württemberg

  • Dossier - 19/09/2011

    Social network services are springing up like mushrooms; everybody seems to be talking about ‘Web 2.0’ or ‘Podcast’. The life sciences are also starting to use the new communication media for their purposes. Social network services are online platforms with a representation of each individual user who links up with a number of different social networks composed of other users. Terms like Web 2.0 and Podcast are commonly used and the World Wide…

  • Dossier - 30/05/2011

    Technology transfer that efficiently exploits the intellectual property created by publicly funded research is necessary in order to turn scientific discoveries into successful innovations that improve people’s quality of life and boost the economy. The efforts made to rapidly transfer research results from the laboratory into clinical application for the benefit of patients leads to new strategic partnerships and structures in the field of…

  • Dossier - 18/10/2010

    Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…

  • Dossier - 09/08/2010

    Biomolecules such as peptides and nucleic acids can nowadays be synthesised relatively quickly and inexpensively. In addition, great progress has been made in the development of methods enabling the directed mutagenesis in microorganisms. These two developments have boosted the design of new, and the reorganisation of known, molecules. Moreover, these help in the utilisation of certain molecule functions in research and in the industrial…

  • Dossier - 14/06/2010

    Synthetic biology is an extension of the spirit of genetic engineering that focuses on the development of biological systems with new, defined characteristics, assembled according to the principles of engineering. Synthetic biology has the potential to be used for a broad range of applications and has solutions in store for major problems of the future, including the sustainable supply of energy and the elimination of environmental damage. As the…

  • Dossier - 16/07/2009

    According to statistics from the European Patent Office, a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years, experts expect that a much larger number of biotech patents will be filed. For life sciences inventors, the registration of patents quite often represents a real challenge. People entering the world of patents and licences, are faced with a…

  • Dossier - 25/05/2009

    Founding a company is a very complex process – especially in knowledge-intensive sectors such as biotechnology. Turning a vague business idea into a successful company is characterised by different phases that place great demands on the qualifications and learning aptitudes of the company founders. Financing and economic organisation often means that company founders have to enter completely unknown new territory.

  • Dossier - 15/07/2008

    Science needs publicity. Publicly funded research has to account for its projects – internally as well as externally. In the past, accounting for projects was a matter dealt with in courtly or academic circles, today the forum is research journals. This "internal" communication seldom reaches the public; however, external communication seeks out the wider (lay) audience - for many reasons.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/biotech